
Infraredx, a Nipro Company
@infraredx
Bringing you the best tools available: the Makoto™ Imaging System & OKAY®II Y-Connector.
The PROSPECT II Study is now published in The Lancet! bit.ly/3qHdj95
ID: 80381802
http://www.infraredx.com 06-10-2009 19:25:27
907 Tweet
521 Followers
790 Following

Today we're starting a campaign to promote a session CRT Meeting to present VULNERABLE TRIAL #COMBINEINTERVENE #INTERCLIMA and #PREVENT trials at the #vulnerable track at the conference. For this edition #CRT2024, do not miss this lecture presented by the Dr. Muller who coined



Want to SEE what all the hype is about? (Literally) Learn how IVUS+NIRS can identify vulnerable plaque and help you prepare the best interventional strategy for your patients! Register here: lnkd.in/exZpHT_v Ziad Ali Allen Jeremias Evan Shlofmitz OPCI American College of Cardiology #ACC24




Fantastic session on the current and future use of Infraredx, a Nipro Company NIRS IVUS. Nodules, DCB, and future therapies. Including the EssexCTC and King's College London NIRS IVUS registry. Nilesh Pareek John Davies Dr S Khan 💛 MSE Research Team 💙 ARU MTRC Mid and South Essex NHS Foundation Trust

Live case with Dr. Matthew Finn at the Cardiovascular Institute of the South ASC in Gray, LA. #ncvh2024



Join Nipro in partnership with OPCI at our September 28th Hands-on Workshop! Gain proficiency in advanced intravascular imaging guidance techniques in complex pci. Open to all ICs and fellows. Register at opci.events/michigan2024 Infraredx, a Nipro Company





HF-OCT total vessel imaging in heart Tx patients—>low catheter profile, lower contrast amount, ideal IVI for OHT? Dr. Hiram Bezerra #TCT2024 Cardiovascular Research Foundation #IVI #OCT #ACCIC







